Metrikler
Yayın
18
Açık Erişim
3
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (17)
SCI-E, SSCI, AHCI (17)
SCI-E, SSCI, AHCI, ESCI (17)
Scopus (17)
TRDizin (1)
2014
20141. Positive Effects of Oral beta-Glucan on Mucositis and Leukopenia in Colorectal Cancer Patients Receiving Adjuvant FOLFOX-4 Combination Chemotherapy
Karaca H., BOZKURT O., Ozaslan E., Baldane S., Berk V., İNANÇ M., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.8, ss.3641-3644, 2014 (SCI-Expanded, Scopus)
2013
20132. Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
KAYA M. F., ÖZKAN M., Gunebakmaz O., Akkaya H., Kaya E. G., Akpek M., et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY
, cilt.167, sa.5, ss.2306-2310, 2013 (SCI-Expanded, Scopus)
2013
20133. D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer
Inanc M., Er O., Karaca H., Berk V., ÖZKAN M., Dikilitas M., et al.
JOURNAL OF BUON
, cilt.18, sa.2, ss.391-397, 2013 (SCI-Expanded, Scopus)
2013
20134. Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer
Eroglu C., ORHAN O., Ünal D., Dogu G. G., Karaca H., Dikilitas M., et al.
ANNALS OF THORACIC MEDICINE
, cilt.8, sa.2, ss.109-115, 2013 (SCI-Expanded, Scopus)
2013
20135. The effect of being overweight on survival in patients with gastric cancer undergoing adjuvant chemoradiotherapy
EROGLU C., ORHAN O., KARACA H., UNAL D., DIKILITAS M., ÖZKAN M., et al.
EUROPEAN JOURNAL OF CANCER CARE
, cilt.22, sa.1, ss.133-140, 2013 (SCI-Expanded, SSCI, Scopus)
2012
20126. Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer
Yildiz R., Benekli M., ÖZKAN M., Alkis N., Berk V., Kaplan M. A., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
, cilt.138, sa.11, ss.1845-1852, 2012 (SCI-Expanded, Scopus)
2012
20127. Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?
ÖZKAN M., Sivgin S., KOÇYİĞİT I., Emirogullari F., Dikilitas M., KAYNAR L., et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
, cilt.8, sa.3, 2012 (SCI-Expanded, Scopus)
2012
20128. Gemcitabine and Cisplatin Combination Chemotherapy in Triple Negative Metastatic Breast Cancer Previously Treated with a Taxane/Anthracycline Chemotherapy; Multicenter Experience
ÖZKAN M., Berk V., Kaplan M. A., Benekli M., Coskun U., Bilici A., et al.
NEOPLASMA
, cilt.59, sa.1, ss.38-42, 2012 (SCI-Expanded, Scopus)
2011
20119. Irinotecan as a Second-line Monotherapy for Small Cell Lung Cancer
Sevinc A., Kalender M. E., Altinbas M., ÖZKAN M., Dikilitas M., Camci C.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.12, sa.4, ss.1055-1059, 2011 (SCI-Expanded, Scopus)
2010
201010. Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature
Karaca H., Lale A., Dikilitas M., ÖZKAN M., Er O.
MEDICAL ONCOLOGY
, cilt.27, sa.3, ss.1023-1026, 2010 (SCI-Expanded, Scopus)
2010
201011. The effect of education given to women with breast cancer on chemotherapy treatment on anxiety levels
Guleser G., TAŞCI S., TOKMAKÇI M., Dikilitas M., Celiksoy A., Horasan P., et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING
, cilt.14, 2010 (SCI-Expanded, SSCI, Scopus)
2010
201012. Hypoglycemia in a Patient With Metastatic Gastrointestinal Stromal Tumor: Is Chemotherapy a Reasonable Option for Symptom Control?
Dogu G. G., Dikilitas M., ÖZKAN M., KARAHAN Ö. I., Karaca Z., Gunay N., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.1, ss.48-51, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
201013. Multiple Gastrointestinal Stromal Tumors and Their Association with Other Rare Tumors: Case Report
Soyuer I., Tasdemir A., ÖZTÜRK F., GÜRSOY Ş., Artis T., Dikilitas M., et al.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, cilt.30, sa.1, ss.361-367, 2010 (SCI-Expanded, Scopus)
2010
201014. Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin
Dogu G. G., ÖZKAN M., ÖZTÜRK F., Dikilitaş M., Er O., ÖZTÜRK A.
MEDICAL ONCOLOGY
, cilt.27, sa.1, ss.34-39, 2010 (SCI-Expanded, Scopus)
2010
201015. Prognostic Value of Excision Repair Cross-complementing Gene 1 Expression for Cisplatin-Based Chemotherapy in Advanced Gastric Cancer
ÖZKAN M., Akbudak I. H., DENİZ K., Dikilitas M., Dogu G. G., Berk V., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.11, sa.1, ss.181-185, 2010 (SCI-Expanded, Scopus)
2008
200816. Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients
Coskun U., Buyukberber S., Yaman E., Uner A., Er O., ÖZKAN M., et al.
NEOPLASMA
, cilt.55, sa.1, ss.65-70, 2008 (SCI-Expanded, Scopus)
2006
200617. Thrombosis and cancer: Clinical, laboratuary and genetic evaluation.
ÖZKAN M., Dikilitas M., KOÇYİĞİT I., Er O., SARI İ., Dogu G., et al.
ANNALS OF ONCOLOGY
, sa.17, ss.301, 2006 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2009
20091. Kemik dışı Ewing sarkomu ve 99mTc MDP sintigrafisinde yaygın kemik metastazı
ABDÜLREZZAK Ü., BERK V., ERDOĞAN Z., KARACA H., DİKİLİTAŞ M., KULA M., et al.
6. Ulusal Tıbbi Onkoloji Kogresi, Türkiye, 24 - 28 Eylül 2009
Desteklenen Projeler
2009 - 2011
2009 - 2011
RADYOTERAPİ TEDAVİSİ ALAN KANSERLİ HASTALARDA FİZYOLOJİK ÖLÇÜMLERE DAYALI STRES DÜZEYİNİN TESPİT EDİLMESİ?
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
TAŞCI S. (Yürütücü), DİKİLİTAŞ M., TOKMAKÇI M., KARA S., GÜLESER G. N., KAPLAN B.
2007 - 2008
2007 - 2008TROMBOZU OLAN VE OLMAYAN SOLİD TÜMÖRLÜ HASTALARDA FAKTÖR V LEİDEN METİLEN TETRAHİDROFOLAT REDÜKTAZ PROTROMBİN VE PAI-1 POLİMORFİZMLERİNİN ARAŞTIRILMASI
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
ÖZKAN M. (Yürütücü), DİKİLİTAŞ M., ÖZKUL Y., KOÇYİĞİT İ., ÜNAL A.